Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	Placebo	0	36
Total, all-cause mortality	Sotagliflozin 75 mg	0	35
Total, all-cause mortality	Sotagliflozin 200 mg	0	35
Total, all-cause mortality	Sotagliflozin 400 mg	0	35
Total, other adverse events	Placebo	10	36
Total, other adverse events	Sotagliflozin 75 mg	5	35
Total, other adverse events	Sotagliflozin 200 mg	6	35
Total, other adverse events	Sotagliflozin 400 mg	4	35
Total, serious adverse events	Placebo	1	36
Total, serious adverse events	Sotagliflozin 75 mg	1	35
Total, serious adverse events	Sotagliflozin 200 mg	1	35
Total, serious adverse events	Sotagliflozin 400 mg	1	35

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02459899/event-totals